how will rising demand and technological developments create opportunities?
The market for pre-filled syringes has achieved growth in recent years. In 2009, an estimated 2 billion pre-filled syringe units were sold and the market for that technology was estimated to be worth up to $2.5 billion. There is a trend towards pre-filled drug injection systems, away from vials/ampules, for both new and existing products. Examples are filled glass and plastic syringes, pens and low-volume auto-injection devices, including refills. That sector has shown growth of 10-15% in recent years, forming one of the fastest-expanding sectors in the pharmaceutical industry. In our new report, we predict that the pre-filled drug delivery market will grow steadily from 2010, as the number of products launched in pre-filled injectable forms increases. Medical professionals, patients and other stakeholders see the benefits of that more-convenient system, raising demand at the expense of older formats. ( http://www.bharatbook.com/detail.asp?id=140902&rt=Pre-Filled-Syringes-and-Relate )
Pre-Filled Syringes and Related Systems: World Market Outlook 2010-2025 shows how a range of therapeutic agents – vaccines, insulins, analogues and many other biologicals – drive growth in that sector. Combined with new pre-filled drug delivery systems and healthcare safety and cost-saving initiatives, the market for pre-filled syringes and similar devices will expand steadily. All the therapeutic segments using pre-filled injectables have been growing in revenue, but which will expand fastest in future? What are the therapeutic and commercial trends to watch? How will the global market for pre-filled syringe-type products perform from 2010 to 2025? Our report answers such questions, providing the information that you need.
The range of pre-filled syringes and related products has broadened into many areas, including:
The pharmaceutical industry accepts pre-filled drug technology as a proven market and the format of choice for many parentally-administered drugs. Because a product’s delivery system can affect patient compliance – influencing therapeutic outcomes, cost-effectiveness and brand image – easier-to-use devices can confer higher sales and market share. Our new report shows how partnerships between companies will be crucial when developing and harnessing pre-filled injection technologies.